05/26/2026
Cancer prevention is not one-size-fits-all. In our newest episode of We Speak Cancer, we speak with Michelle Zimmerman, Founder and CEO of Previvor Edge, about the future of personalized cancer prevention, risk assessment, and proactive screening.
Michelle shares how professional experience in healthcare innovation, combined with a deeply personal family history of cancer, inspired her to build a platform focused on helping individuals better understand their personal cancer risk before a diagnosis occurs.
This conversation explores important questions many patients, caregivers, and families face:
How does family history influence cancer risk?
When should someone ask about earlier or different screenings?
What role do symptoms, genetics, lifestyle, environment, and prior screening results play in prevention?
How can patients feel more informed and empowered when navigating conversations with their care team?
One of the most powerful takeaways from this episode is the importance of having a plan. For some individuals, standard screenings may not be enough. Understanding personal risk can help guide more informed conversations with clinicians, create opportunities for earlier detection, and support prevention strategies tailored to each person.
At The Chemotherapy+ Foundation, we believe education, research, and collaboration are essential to advancing cancer prevention and treatment. Conversations like this help bridge the gap between patients, clinicians, caregivers, and innovators working toward a future where more cancers are caught earlier or prevented altogether.
Watch Episode 4 here:
https://youtu.be/asMVXWzsNWQ?si=Jd1Akod4aM_LyYZs
Welcome to We Speak Cancer — the official podcast of The Chemotherapy+ Foundation, where we discuss cancer, survivorship, research, and the future of cancer ...